BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 12436384)

  • 1. [Treatment of Alzheimer's disease].
    López OL; Becker JT
    Rev Neurol; 2002 Nov 1-15; 35(9):850-9. PubMed ID: 12436384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic treatment of Alzheimer's disease: an update.
    DeLaGarza VW
    Am Fam Physician; 2003 Oct; 68(7):1365-72. PubMed ID: 14567491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rivastigmine: a review of its clinical effectiveness].
    Spiegel R
    Rev Neurol; 2002 Nov 1-15; 35(9):859-69. PubMed ID: 12436385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease: clinical treatment options.
    Reichman WE
    Am J Manag Care; 2000 Dec; 6(22 Suppl):S1125-32; discussion S1133-8. PubMed ID: 11142177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trials and perspectives in pharmacotherapy of Alzheimer's disease].
    Kieszek S
    Psychiatr Pol; 1999; 33(3):331-40. PubMed ID: 10786233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's disease.
    Grossberg GT
    Curr Med Res Opin; 2005 Oct; 21(10):1631-9. PubMed ID: 16238903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Have cholinergic therapies reached their clinical boundary in Alzheimer's disease?
    Jones RW
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S7-S13. PubMed ID: 12973745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease: seeking new ways to preserve brain function. Interview by Alice V. Luddington.
    Davis KL
    Geriatrics; 1999 Feb; 54(2):42-7; quiz 48. PubMed ID: 10024872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical treatment of cognitive disorders in Alzheimer's disease.
    Senin U; Cherubini A; Palumbo B; Mecocci P
    Funct Neurol; 1997; 12(3-4):211-2. PubMed ID: 9218980
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neuropathology of Alzheimer's disease and mild cognitive impairment].
    López OL; DeKosky ST
    Rev Neurol; 2003 Jul 16-31; 37(2):155-63. PubMed ID: 12938076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review on cholinesterase inhibitors for Alzheimer's disease.
    Anand P; Singh B
    Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection].
    Behl C; Holsboer F
    Fortschr Neurol Psychiatr; 1998 Mar; 66(3):113-21. PubMed ID: 9565761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease pathogenesis and therapeutic interventions.
    Parihar MS; Hemnani T
    J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New drugs for Alzheimer's disease.
    Delagarza VW
    Am Fam Physician; 1998 Oct; 58(5):1175-82. PubMed ID: 9787282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacotherapy of Alzheimer dementia: therapy of cognitive symptoms--new results of clinical studies].
    Heidrich A; Rösler M; Riederer P
    Fortschr Neurol Psychiatr; 1997 Mar; 65(3):108-21. PubMed ID: 9173033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current approaches in the treatment of Alzheimer's disease.
    Shah RS; Lee HG; Xiongwei Z; Perry G; Smith MA; Castellani RJ
    Biomed Pharmacother; 2008; 62(4):199-207. PubMed ID: 18407457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanisms of neurodegenerative processes and current pharmacotherapy of Alzheimer's disease.
    Gongadze N; Antelava N; Kezeli T; Okudjava M; Pachkoria K
    Georgian Med News; 2008 Feb; (155):44-8. PubMed ID: 18401056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Alzheimer's disease].
    Bombois S; Lebert F; Vellas B; Pasquier F
    Rev Prat; 2005 Nov; 55(17):1913-9. PubMed ID: 16396232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.